Science
Pat Soon-Shiong: WCLC26 Advances the Conversation on Immune Biomarkers in NSCLC
Patrick Soon-Shiong/X

Pat Soon-Shiong: WCLC26 Advances the Conversation on Immune Biomarkers in NSCLC

Pat Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive Chairman of the Los Angeles Times, shared on X:

“Our ImmunityBio team is having great reception at World Conference Lung Cancer (WCLC26) in Seoul Korea discussing ReQ201A-NSCLC (Phase 3).

The world is waking up to the fact that ALC (absolute lymphocyte count) and Natural Killer (NK) cells matter to prolong life.

The conclusion from the Chudzik abstract is consistent with what we saw in QUILT-3.055.”

Title: P3.175: Peripheral Blood Immunophenotyping Reveals Patterns of Short and Durable Immunotherapy Response in NSCLC

Authors: Robert Chudzik, N. Krzyżanowska, K. Wojas Krawczyk, T. Kucharczyk, I. Chmielewska, M. Wójcik-Superczyńska, T. Janowski, P. Krawczyk, J. Milanowski

Read the full abstract.

You can also read:

HARMONi-2 Shows Overall Survival Benefit With Ivonescimab Over Pembrolizumab in First-Line PD-L1–Positive NSCLC

Pat Soon-Shiong: WCLC26 Advances the Conversation on Immune Biomarkers in NSCLC

ALC cancer I. Chmielewska ImmunityBio J. Milanowski K. Wojas Krawczyk Lung cancer M. Wójcik-Superczyńska N. Krzyżanowska Natural Killer (NK) NSCLC OncoDaily Oncology P. Krawczyk Pat Soon-Shiong Robert Chudzik T. Janowski T. Kucharczyk WCLC26 World Conference Lung Cancer